Building has equipment for modified-release technology, formulation development rooms, and consulting offices.
PharmEng, a consulting and contract manufacturing company, opened a $15 million pharmaceutical manufacturing facility in North Sydney, Nova Scotia.
The 46,400 sq.ft. facility located on five acres operates under the name of Keata Pharma and includes offices for PharmEng’s pharmaceutical consulting division, pilot laboratories for formulation development, equipment for modified-release technology, and rooms with various capabilities such as high shear mixing and container blending all in a control environment that meets all cGMP requirements.
The facility will have the necessary equipment and approvals to provide formulation development and testing services to manufacture and package products in solid and liquid dosage forms, reports the company. Keata’s long-term goal is to develop capabilities in other dosage forms, such as suppositories, topicals, and injectables.
The facility will initially employ 65 workers and is anticipated to grow to in excess of 150 workers within three years, according to the company. Production is expected to commence in early Q1 of 2008.
